Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tumbarello

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|May 29, 1993
Primary central nervous system lymphoma and brain biopsy in AIDSA Antinori, A Ammassari, R Murri, et al.
Viral Immunology|January 1, 1991
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2S K Tyring, R Cauda, M Tumbarello, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 20, 2001
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapiesM Tumbarello, E Tacconelli, K G de Donati, et al.
The European Respiratory Journal|June 13, 2001
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcomeM Tumbarello, E Tacconelli, K de Gaetano Donati, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 1998
Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importanceL Pagano, E Tacconelli, M Tumbarello, et al.
British Journal of Addiction|May 1, 1990
Risk behaviour and HTLV-1 seropositivity in injecting drug usersG Rezza, A Lazzarin, C Uberti-Foppa, et al.
Journal of Chemotherapy (Florence, Italy)|June 26, 2004
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcomeS Bertagnolio, K de Gaetano Donati, E Tacconelli, et al.
The Journal of Hospital Infection|March 9, 2000
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infectionE Tacconelli, M Tumbarello, K de Gaetano Donati, et al.
The Journal of Infection|January 1, 1997
Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infectionM Tumbarello, E Tacconelli, L Pagano, et al.
Immunology Letters|September 1, 1995
P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patientsM B Lucia, R Cauda, W Malorni, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|May 29, 1993
Primary central nervous system lymphoma and brain biopsy in AIDSA Antinori, A Ammassari, R Murri, et al.
Viral Immunology|January 1, 1991
Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin-1 and tumor necrosis factor but depress production of interferon-alpha, interferon-gamma and interleukin-2S K Tyring, R Cauda, M Tumbarello, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 20, 2001
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapiesM Tumbarello, E Tacconelli, K G de Donati, et al.
The European Respiratory Journal|June 13, 2001
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcomeM Tumbarello, E Tacconelli, K de Gaetano Donati, et al.
The Journal of Antimicrobial Chemotherapy|January 8, 1998
Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importanceL Pagano, E Tacconelli, M Tumbarello, et al.
British Journal of Addiction|May 1, 1990
Risk behaviour and HTLV-1 seropositivity in injecting drug usersG Rezza, A Lazzarin, C Uberti-Foppa, et al.
Journal of Chemotherapy (Florence, Italy)|June 26, 2004
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcomeS Bertagnolio, K de Gaetano Donati, E Tacconelli, et al.
The Journal of Hospital Infection|March 9, 2000
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infectionE Tacconelli, M Tumbarello, K de Gaetano Donati, et al.
The Journal of Infection|January 1, 1997
Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infectionM Tumbarello, E Tacconelli, L Pagano, et al.
Immunology Letters|September 1, 1995
P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patientsM B Lucia, R Cauda, W Malorni, et al.
Pageof 10